Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Eli Lilly & Co (LLY)  
$905.38 3.66 (0.4%) as of 4:30 Fri 6/28


Download
   
Exchange: New York Stock Exchange
Security Type: Common
Shares Out: 956,580,000
Market Cap: 866.07(B)
Last Volume: 3,374,911 Avg Vol: 3,268,697
52 Week Range: $434.7 - $909.04
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Drug Manufacturers - Major

Member Indexes:
    S&P COMPOSITE 1500     NYSE COMPOSITE
    S&P 500

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  720
Guru Rank Value     : 1.4
Guru Occurances    : 2

 

            6 Months   1 Year   2 Year  
 
Company Profile   Eli Lilly and Company discovers, develops, manufactures, and markets products in a single business segment: human pharmaceutical products. Co.'s products include: diabetes products, oncology products, immunology products, neuroscience products, and other therapies. Co.'s diabetes products include: Baqsimi®, Basaglar®, Humalog®, Humulin®, Jardiance®, Lyumjev®, Trajenta®, and Trulicity®. Co.'s oncology products include: Alimta®, Cyramza®, Erbitux®, Retevmo®, Tyvyt®, and Verzenio®. Co.'s immunology products include: Olumiant® and Taltz®. Co.'s neuroscience products include: Cymbalta®, Emgality®, Reyvow®, and Zyprexa®. Co.'s other therapies include: Bamlanivimab, Cialis®, and Forteo®.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 656
Total Buy Value $0 $0 $0 $199,549
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 1
Total Shares Sold 1,520,577 2,391,327 3,771,329 6,318,238
Total Sell Value $1,284,658,855 $1,892,909,435 $2,147,483,647 $2,147,483,647
Total People Sold 3 3 4 6
Total Sell Transactions 18 31 50 93
End Date 2024-03-31 2023-12-29 2023-06-30 2022-06-30

   
Records found: 1436
  Page 48 of 58  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Fry Stephen F SVP, HR & Diversity   •       –      –    2016-02-01 4 OE $0.00 $0 D/D 7,252 81,467     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2016-02-01 4 D $79.10 $385,375 D/D (4,872) 113,572     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2016-02-01 4 OE $0.00 $0 D/D 10,360 118,444     -
   Crowe Maria A President, Mfg. Operations   •       –      –    2016-02-01 4 D $79.10 $261,584 D/D (3,307) 82,504     -
   Crowe Maria A President, Mfg. Operations   •       –      –    2016-02-01 4 OE $0.00 $0 D/D 7,252 85,811     -
   Barnes Melissa S Chief Eth/Cmpl Ofcr & SVP, ERM   •       –      –    2016-02-01 4 D $79.10 $51,890 D/D (656) 11,702     -
   Barnes Melissa S Chief Eth/Cmpl Ofcr & SVP, ERM   •       –      –    2016-02-01 4 OE $0.00 $0 D/D 2,072 12,358     -
   Marram Ellen R Director   –       •      –    2016-01-29 4 A $83.23 $6,575 D/D 79 45,914     -
   Alvarez Ralph Director   –       •      –    2016-01-29 4 A $83.23 $9,904 D/D 119 30,671     -
   Zulueta Alfonso G SVP& Pres., Emerging Markets   •       –      –    2016-01-29 4 S $78.75 $393,750 D/D (5,000) 57,101     -
   Zakrowski Donald A Chief Accounting Officer   •       –      –    2016-01-26 4 A $81.96 $164,166 D/D 2,003 5,849     -
   Barnes Melissa S Chief Eth/Cmpl Ofcr & SVP, ERM   •       –      –    2016-01-26 4 A $81.96 $382,098 D/D 4,662 10,286     -
   Harrington Michael J Senior VP and General Counsel   •       –      –    2016-01-26 4 A $81.96 $1,472,084 D/D 17,961 55,043     -
   Zulueta Alfonso G SVP& Pres., Emerging Markets   •       –      –    2016-01-26 4 A $81.96 $576,589 D/D 7,035 62,101     -
   Lundberg Jan M EVP,Science&Tech and Pres. LRL   •       –      –    2016-01-26 4 A $81.96 $2,383,479 D/D 29,081 106,501     -
   Fry Stephen F SVP, HR & Diversity   •       –      –    2016-01-26 4 A $81.96 $1,190,469 D/D 14,525 74,215     -
   Conterno Enrique A Sr. VP & Pres., Lilly Diabetes   •       –      –    2016-01-26 4 A $81.96 $1,635,348 D/D 19,953 108,084     -
   Simmons Jeffrey N SVP&Pres. Elanco Animal Health   •       –      –    2016-01-26 4 A $81.96 $1,585,434 D/D 19,344 108,700     -
   Crowe Maria A President, Mfg. Operations   •       –      –    2016-01-26 4 A $81.96 $1,218,909 D/D 14,872 78,559     -
   Ricks David A SVP and Pres, Lilly Bio-Meds   •       –      –    2016-01-26 4 A $81.96 $1,558,551 D/D 19,016 79,949     -
   Walsh Fionnuala M SVP, Global Quality   •       –      –    2016-01-26 4 A $81.96 $580,359 I/I 7,081 29,659     -
   Walsh Fionnuala M SVP, Global Quality   •       –      –    2016-01-26 4 A $81.96 $741,000 D/D 9,041 52,450     -
   Lechleiter John C Chairman, President and CEO   •       •      –    2016-01-26 4 A $81.96 $6,879,640 D/D 83,939 726,488     -
   Peterson Barton R Sr. VP, Corp. Affairs & Comm.   •       –      –    2016-01-26 4 A $81.96 $965,899 D/D 11,785 91,190     -
   Rice Derica W EVP-Global Services and CFO   •       –      –    2016-01-26 4 A $81.96 $3,022,275 D/D 36,875 36,875     -
  1436 Records found
  Previous  40  41  42  43  44  45  46  47  48  49  Next   
  Page 48 of 58
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us